Riding on a surge in global demand for its patented obesity and diabetes medicines Ozempic, Wegovy and Rybelsus, ...

PFE's decision to scrap the development of danuglipron comes after a study participant develops potential drug-induced liver injury.

India's anti-obesity drug market shows significant growth. It has increased fourfold in five years. Lifestyle diseases and ...

Pfizer decided to abort the clinical trial of its daily weight loss pill 'Danuglipron' after one patient in a trial showed signs of liver damage, likely to be caused by the drug.

Ryan Rasmussen was determined to lose weight so he would be around to ski and spend time with his wife and children.

Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting ...

Rybelsus (semaglutide) and Ozempic (semaglutide) are prescription drugs used to treat type 2 diabetes. Rybelsus comes as an oral tablet, while Ozempic comes as an injectable liquid solution.

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

The announcement adds to a string of setbacks in Pfizer’s bid to win a slice of the booming market that Wall Street projects ...

The stock of U.S. pharmaceutical giant Eli Lilly (LLY) is up 3% on news that rival Pfizer (PFE) has ended development of its experimental weight loss pill. Filter, analyze, and streamline your search ...

U.S. pharmaceutical giant Pfizer (PFE) has ended development of its experimental weight loss pill after a patient experienced ...